- Jan 18, 2001
- 3,506
- 1,178
- 113
- School/Org
- ODwire
- City
- Lansdale
- State
- PA
OCULUS, Inc., the American subsidiary of German ophthalmic device manufacturer OCULUS Optikgeräte GmbH, announces that its Smartfield perimeter has launched aboard the International Space Station (ISS) to aid groundbreaking research on Spaceflight Associated Neuro-ocular Syndrome (SANS), a condition affecting astronauts’ vision during long-duration spaceflight.
The Smartfield, a compact and portable visual field analyzer, will help researchers study how microgravity impacts ocular health. Insights from this work may also benefit patients on Earth by advancing understanding of neuro-ocular conditions and improving clinical care.
Selected for its small footprint, reliability, and efficiency, the Smartfield is ideally suited to the unique environment of space. Its deployment aboard the ISS highlights the growing role of advanced ophthalmic technology in both clinical practice and scientific discovery.
“We are honored that the Smartfield is contributing to such critical research aboard the ISS and that the device is playing a key role in preserving the safety of our brave astronauts,” says Bill Tullo, OD, OCULUS, Inc. “This milestone underscores our commitment to advancing vision care with innovative solutions, both here on Earth and beyond.”
The OCULUS Smartfield remains a trusted solution for visual field testing in glaucoma management and neuro-ophthalmic assessment worldwide. For more information, visit: www.oculususa.com/products/smartfield.
About OCULUS, Inc. | OCULUS, Inc. is the American subsidiary of German ophthalmic diagnostic device designer and manufacturer OCULUS, which has operated as a trusted partner for eye care professionals since 1895. Founded in 1999, OCULUS, Inc. (USA) combines German engineering with exceptional customer service to deliver best-in-class ophthalmic diagnostic solutions, device training, and product support to American eye care practitioners.
The Smartfield, a compact and portable visual field analyzer, will help researchers study how microgravity impacts ocular health. Insights from this work may also benefit patients on Earth by advancing understanding of neuro-ocular conditions and improving clinical care.
Selected for its small footprint, reliability, and efficiency, the Smartfield is ideally suited to the unique environment of space. Its deployment aboard the ISS highlights the growing role of advanced ophthalmic technology in both clinical practice and scientific discovery.
“We are honored that the Smartfield is contributing to such critical research aboard the ISS and that the device is playing a key role in preserving the safety of our brave astronauts,” says Bill Tullo, OD, OCULUS, Inc. “This milestone underscores our commitment to advancing vision care with innovative solutions, both here on Earth and beyond.”
The OCULUS Smartfield remains a trusted solution for visual field testing in glaucoma management and neuro-ophthalmic assessment worldwide. For more information, visit: www.oculususa.com/products/smartfield.
About OCULUS, Inc. | OCULUS, Inc. is the American subsidiary of German ophthalmic diagnostic device designer and manufacturer OCULUS, which has operated as a trusted partner for eye care professionals since 1895. Founded in 1999, OCULUS, Inc. (USA) combines German engineering with exceptional customer service to deliver best-in-class ophthalmic diagnostic solutions, device training, and product support to American eye care practitioners.
